Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk

Sponsor
University of South Carolina (Other)
Overall Status
Completed
CT.gov ID
NCT01377064
Collaborator
National Institute of Nursing Research (NINR) (NIH)
60
2
2
28
30
1.1

Study Details

Study Description

Brief Summary

Because of advances in drug treatment, people living with HIV/AIDS (PLWHA) are living longer, but are also at greater risk for cardiovascular disease (CVD) and diabetes. Exercise and increased physical activity can reduce the risk factors for these diseases in PLWHA, but no studies have tested an at-home exercise program that would benefit low income people and others who do not have access to exercise facilities. This study will test the feasibility of an at-home exercise program for PLWHA and prepare for a full-scale intervention study, which may lead to a reduction in CVD risk among PLWHA.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Physical Activity Group
  • Other: Standard Care Group
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Home-based Exercise for Management of HIV-associated Cardiovascular Disease
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Jul 1, 2013
Actual Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Physical activity group

Subjects will participant in physical activity program

Behavioral: Physical Activity Group
9 months of home based physical activity meeting HHS recommendations for physical activity for all americans

Active Comparator: Standard care group

This group will not receive a physical activity intervention

Other: Standard Care Group
No intervention, the group will be followed under their standard medical care.

Outcome Measures

Primary Outcome Measures

  1. Amount of Physical Activity [9 months]

    Accelerometer data will be the primary means of determining the participants' physical activity levels. Participants will be instructed to wear the accelerometer at baseline, 4 months, and 9 months. The participants will be required to wear the accelerometer during the waking hours for seven consecutive days. Data from participants with at least four days and at least 10 hours per day will be included.

Secondary Outcome Measures

  1. Cardiorespiratory Fitness [9 months]

    Each participant will complete a graded exercise stress test (GXT) with indirect calorimetry. This test will be used to screen for abnormal physiological responses to exercise and for determining the participant's maximal ability to utilize oxygen (an index of cardiorespiratory fitness).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 years and older

  • Medical diagnosis of HIV-1 positive serostatus

  • Sedentary lifestyle: not actively exercising ≥ 3 d•wk-1 for 20 min per session

  • 18.5 kg/m2 < BMI < 40.0 kg/m2

  • Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL

  • Capable of performing the required exercise regimen

  • Have daily access to a telephone for approximately 10 months

  • Capacity and willingness to provide informed consent and accept randomized group assignment

Exclusion Criteria:
  • Individuals who have a clinical history strongly suggestive of Type 1 diabetes.

  • History of serious arrythmias, cardiomyopathy, congestive heart failure, stroke or transient ischemic cerebral attacks, peripheral vascular disease with intermittent claudication, myocardial infarction, or CABG.

  • Malignancies in the past 5 years, except therapeutically controlled skin cancer.

  • Plans to be away > 4 weeks in the next 9 months

  • Score of 5 or greater on the DAST or MAST (signifying excessive use of drugs or alcohol).

  • Weight loss in excess of 10% body weight in previous 12 weeks.

  • Chronic or recurrent respiratory, gastrointestinal, neuromuscular, neurological, or psychiatric conditions.

  • Inflammatory-related conditions such as collagen disorders.

  • Any other medical condition or disease that is life-threatening or that can interfere with or be aggravated by exercise.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Citadel Charleston South Carolina United States 29425
2 University of South Carolina Columbia South Carolina United States 29208

Sponsors and Collaborators

  • University of South Carolina
  • National Institute of Nursing Research (NINR)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of South Carolina
ClinicalTrials.gov Identifier:
NCT01377064
Other Study ID Numbers:
  • Pro00007339
  • 1R21NR011281
First Posted:
Jun 20, 2011
Last Update Posted:
Apr 28, 2021
Last Verified:
Apr 1, 2021
Keywords provided by University of South Carolina
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2021